A Look At Abiomed Before The $380/Share Buyout From Johnson & Johnson
Summary: JNJ's agreed acquisition of ABMD at $380 per share came as a surprise to many healthcare focused investors.ABMD's...
Tag: ABMD
Abiomed: Correction Offers Good Buying Opportunity
Summary: Abiomed’s Impella range of micro heart pumps enjoy rising demand in the marketplace.The company’s OXY-1 System...
Abiomed: Small Premium For Access To ~11% Normalized ROIC
Summary: Abiomed came in with another set of robust earnings yesterday, with double-digit growth from top to...
Abiomed’s Profit Growth Slows On R&D, Sales Hold Strong Despite Shortages
Summary: ABMD had a decent quarter where revenues grew nicely but profits languished due to sudden growth in R&D...
Abiomed’s Less Troubled 2020 Justifies Multiple, But Medium-Term Headwinds Mean Capital Risk
Summary: Abiomed is a company with a superb product in the mid-market space while what appears on the surface is an...